Abstract:Several small-molecule CDK inhibitors have been identified, but none have been approved for clinical use in the past few years. A new series of 4-[(3-hydroxybenzylamino)-methylene]-4H-isoquinoline-1,3-diones were reported as highly potent and selective CDK4 inhibitors. In order to find more potent CDK4 inhibitors, the interactions between these novel isoquinoline-1,3-diones and cyclin-dependent kinase 4 was explored via in silico methodologies such as 3D-QSAR and docking on eighty-one compounds displaying potent selective activities against cyclin-dependent kinase 4. Internal and external cross-validation techniques were investigated as well as region focusing, bootstraping and leave-group-out. A training set of 66 compounds gave the satisfactory CoMFA model (q2 = 0.695, r2 = 0.947) and CoMSIA model (q2 = 0.641, r2 = 0.933). The remaining 15 compounds as a test set also gave good external predictive abilities with r2pred values of 0.875 and 0.769 for CoMFA and CoMSIA, respectively. The 3D-QSAR models generated here predicted that all five parameters are important for activity toward CDK4. Surflex-dock results, coincident with CoMFA/CoMSIA contour maps, gave the path for binding mode exploration between the inhibitors and CDK4 protein. Based on the QSAR and docking models, twenty new potent molecules have been designed and predicted better than the most active compound 12 in the literatures. The QSAR, docking and interactions analysis expand the structure-activity relationships of constrained isoquinoline-1,3-diones and contribute towards the development of more active CDK4 subtype-selective inhibitors.

Global, Local and Novel Consensus Quantitative Structure-Activity Relationship Studies of 4-(Phenylaminomethylene) Isoquinoline-1, 3 (2H, 4H)-Diones As Potent Inhibitors of the Cyclin-Dependent Kinase 4.

3D-QSAR Study for Inhibitors of Cyclin-Dependent Kinase 4

Molecular-docking-guided 3D-QSAR Studies of Substituted Isoquinoline-1,3-(2h,4h)-diones As Cyclin-Dependent Kinase 4 (CDK4) Inhibitors.

Insight into the Interactions Between Novel Isoquinolin-1,3-dione Derivatives and Cyclin-Dependent Kinase 4 Combining QSAR and Molecular Docking.

3D-QSAR and Molecular Docking Study on Selectivity of Indolocarbazole Series As Cyclin-Dependent Kinase Inhibitors

Enhanced Replacement Method‐based Quantitative Structure–Activity Relationship Modeling and Support Vector Machine Classification of 4‐anilino‐3‐quinolinecarbonitriles As Src Kinase Inhibitors

Discovery of 4-Thiazol-N-(pyridin-2-yl)pyrimidin-2-amine as Novel Cyclin-dependent Kinases 4 and 6 Dual Inhibitors via 3<i>D</i>-QSAR and Molecular Simulation

D-QSAR studies on pyrimidine analogues as cyclin-dependent kinase 1 inhibitors

Molecular modelling on small molecular CDK2 inhibitors: an integrated approach using a combination of molecular docking, 3D-QSAR and pharmacophore modelling.

3D-QSAR and Molecular Docking Approaches for the Identification of Novel Phyto-inhibitors of the Cyclin-dependent Kinase 4

Structure-Activity Relationship Study of Oxindole-Based Inhibitors of Cyclin-Dependent Kinases Based on Least-Squares Support Vector Machines

3D-QSAR and 3D-QSSR Studies of Thieno[2,3-D]pyrimidin-4-yl Hydrazone Analogues As CDK4 Inhibitors by CoMFA Analysis

Development of in Silico Models for Pyrazoles and Pyrimidine Derivatives As Cyclin-Dependent Kinase 2 Inhibitors

Structural Requirements of Isoquinolones As Novel Selective C-Jun N-terminal Kinase 1 Inhibitors: 2D and 3D QSAR Analyses.

3D-QSAR and Docking Studies on Pyrazolo[4,3-H]qinazoline-3-carboxamides As Cyclin-Dependent Kinase 2 (CDK2) Inhibitors.

3D‐QSAR, Molecular Docking and Molecular Dynamics Analysis of 1,2,3,4‐tetrahydroquinoxalines As BRD4/BD2 Inhibitors

QSAR Study of Malonyl-Coa Decarboxylase Inhibitors Using GA-MLR and a New Strategy of Consensus Modeling.

QSAR and Classification Models of a Novel Series of COX-2 Selective Inhibitors: 1, 5-Diarylimidazoles Based on Support Vector Machines

Investigations on Inhibitors of Hedgehog Signal Pathway: A Quantitative Structure-Activity Relationship Study

Validated Quantitative Structure–activity Relationship Analysis of a Series of 2-Aminothiazole Based P56lck Inhibitors

QSAR Studies on 4-Anilino-3-quinolinecarbonitriles As Src Kinase Inhibitors Using Robust PCA and Both Linear and Nonlinear Models